Kon-Kiki Pharma ApS

CVR 43311824 · Private limited company (ApS) · Active · Low risk

Kon-Kiki Pharma ApS is a Private limited company (ApS), founded on , based in Roskilde. The company is registered in the industry virksomhedsrådgivning og anden ledelsesrådgivning. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 4 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 460k and a net result of DKK 420k. CEO: Kiki Atting Andersen.

Bankruptcy risk for Kon-Kiki Pharma ApS

0.0%
probability of bankruptcy within 12 months
Low risk

0.0 × the average (1.41%) · higher risk than 18% of active Danish companies

Lowest riskHighest risk

Increases the risk

Age (years)3–5 yrs · bankruptcy rate 13.3%1.5×
Auditor's statementNo assurance · bankruptcy rate 13.2%1.5×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
Published annual reports3–5 · bankruptcy rate 11.7%1.3×
Time since new CEO2–5 yrs · bankruptcy rate 10.8%1.2×
Audit opted outYes · bankruptcy rate 10.4%1.2×
Auditor registered in CVRNo · bankruptcy rate 10.4%1.2×

Reduces the risk

Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Current ratio200%–500% · bankruptcy rate 3.4%0.39×
Gross profit growth0%–10% · bankruptcy rate 3.5%0.39×
Equity ratio40%–60% · bankruptcy rate 4.6%0.52×
Return on assets15%+ · bankruptcy rate 5.1%0.58×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Loss for the yearNo · bankruptcy rate 5.3%0.60×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
43311824
Status
Active
Company type
Private limited company (ApS)
Founded
(4 years)
Address
Stålmosevej 33
4000 Roskilde
Municipality
Roskilde
Industry
Virksomhedsrådgivning og anden ledelsesrådgivning (702000)
Bankruptcies in the industry: Virksomhedsrådgivning og anden rådgivning om driftsledelse
Share capital
DKK 40k
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 4
Missing annual reportNo
Negative equityNo
Equity ratio54.9%
Current ratio222%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address1
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK 1.5mDKK 1.5m
Net profitDKK 420kDKK 503k
EquityDKK 460kDKK 559k
Total assetsDKK 839kDKK 969k
CashDKK 583k–
Short-term debtDKK 378k–
Tax owedDKK 151k–
Avg. employees1–

Latest annual report: Reporting class B · auditor's statement: No assurance.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 202554
1 Jan 2024 – 31 Dec 202489
1 Jan 2023 – 31 Dec 202316
7 Jun 2022 – 31 Dec 2022104

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOKiki Atting AndersenCurrent
Owner (100%)Kiki Andersen Holding ApSCurrent
FounderKiki Andersen Holding ApSCurrent

The CEOs' other companies

Kiki Atting Andersen – 1 other companies

Address history (0 moves)

Stålmosevej 33, 4000 Roskilde

Other companies at the same address

Similar companies in Roskilde

Questions and answers about Kon-Kiki Pharma ApS

Has Kon-Kiki Pharma ApS gone bankrupt?

No, Kon-Kiki Pharma ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Kon-Kiki Pharma ApS?

Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.

Who is the CEO of Kon-Kiki Pharma ApS?

Kiki Atting Andersen is the CEO of Kon-Kiki Pharma ApS.

When was Kon-Kiki Pharma ApS founded?

Kon-Kiki Pharma ApS was founded on 7 June 2022.

What is the equity of Kon-Kiki Pharma ApS?

Equity was DKK 460k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.